Miguel Xavier
Fernandes
Investigador en el periodo 2013-2022
![Foto de Miguel Xavier](/img/nophoto.png)
![Foto de Hospital Universitario de Canarias](/img/noimage_org.png)
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Canarias (4)
2022
2021
-
Small molecule-based enzyme inhibitors in the treatment of primary hyperoxalurias
Journal of Personalized Medicine, Vol. 11, Núm. 2, pp. 1-31
2019
-
Inhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus
American Journal of Transplantation, Vol. 19, Núm. 12, pp. 3240-3249
2018
-
Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1
Journal of Medicinal Chemistry, Vol. 61, Núm. 16, pp. 7144-7167